3/19
Perelman School of Medicine
Decentralizing cancer screenings
A Projects for Progress team in the Abramson Cancer Center continues to work with the West Philadelphia community to bring cancer screenings out of clinical settings.
For pregnant people in states with most restrictive abortion policies, higher rates of cardiovascular complications
New research from Penn Medicine finds that states with tighter restraints on abortion may be tied to higher maternal morbidity and mortality, the effects of which may extend beyond pregnancy.
Penn Medicine studies unlock new insights into gene therapy
The studies on AAV-based gene therapies in non-human primates suggest that integration into human DNA is unlikely to drive cancer mutations.
Channeling resilience and passion toward a vision for the future
Between her third and fourth years at the Perelman School of Medicine, Fulbright Scholar Zonía Moore worked out of Hospital Manuel Gea González in Mexico City.
Cardiovascular deaths due to extreme heat expected to rise
A new study from researchers at Penn’s Perelman School of Medicine indicates that older adults and Black adults are at greater risk of excess deaths.
How cell developmental biology fits into the future of medicine
Ben Stanger, the Hanna Wise Professor in Cancer Research and professor of medicine and cell and developmental biology, discusses his research and publishing his first book, ‘From One Cell: A Journey into Life’s Origins and the Future of Medicine.’
A ‘thermometer’ tool to measure tumor growth between scans
Researchers at Penn Medicine have developed a first-ever tool that gives a real-time assessment of tumors to provide less uncertainty for patients worrying between scans.
New office supports the Penn postdoc experience
The Office of Postdoctoral Affairs was established this past spring as a boost to the general postdoc community, providing centralized resources, information, and events.
A new understanding of immune response during SARS-CoV-2 breakthrough infections
New research by Penn Medicine finds T cells to be a critical defense against severe illness in the first days after infection, giving clues that could lead to stronger vaccines.
Uncovering the role of skin microbiome and immune response in cutaneous leishmaniasis
Two new studies led by Phillip Scott of the School of Veterinary Medicine and Elizabeth Grice of the Perelman School of Medicine demonstrate how bacteria found in leishmaniasis skin lesions and an associated immune response drive disease burden and treatment failure—and suggest new possibilities for treatment of the parasitic disease.
In the News
Sugar-coated gold nanoparticles could replace some antibiotics
According to a Penn Medicine study, a new therapy involving laser light and sugar-coated gold nanoparticles can reduce tooth decay and infected wounds without needing antibiotics.
FULL STORY →
A new strategy to attack aggressive brain cancer shrank tumors in two early tests
A clinical trial led by Stephen Bagley of the Perelman School of Medicine suggests that targeting two associated proteins with CAR T cell therapy could be a viable strategy for shrinking brain tumors.
FULL STORY →
Alzheimer’s may be caused by a build-up of fat in brain cells
A study by Michael Haney of the Perelman School of Medicine suggests that the root cause of Alzheimer’s is a build-up of fat droplets in brain cells.
FULL STORY →
Philadelphia hospital program adds psychologists to bridge mental health services for trauma survivors
A new psychology team at the Penn Trauma Violence Recovery Program has provided about 46 survivors with short- and long- term therapy, featuring remarks from Elinore Kaufman and Lily Brown of the Perelman School of Medicine.
FULL STORY →
Social factors may ‘disproportionately’ affect transplant process
A 2023 study led by researchers at Penn found that 44% of patients evaluated for liver transplants were not placed on organ wait lists, with nearly 17% rejected because of psychosocial or financial reasons. Marina Serper and Tamara Cozzi of Penn Medicine discuss the evaluation process for transplants.
FULL STORY →